Who founded Definigen?

Definigen was founded by Christopher Trummer, Ola Spjuth, Jordi Carreras-Puigvert, Morgan Ekmefjord.

Who are Definigen's investors?

Definigen's investors include Almi Invest, Nordic Science Investments, 24 Haymarket.

Where is Definigen headquartered?

Definigen is headquartered in Uppsala, SE.

Definigen

Uppsala, SE · 3 known investors

Find your way into Definigen

390 people in our graph share verified history with the Definigen team — schools, employers, funds. One of them is your warm intro.

Eduard Feliuunlockedknows Jordi Carreras-Puigvert · together at Universitat Autònoma de Barcelona (overlapped)

×3knows the team · via Uppsala University

×3knows the team · via Universitat Autònoma de Barcelona

×5knows the team · via Leiden University

Definigen manufactures iPSC-derived human hepatocytes for drug discovery and disease modeling. The product line supports preclinical toxicity testing, metabolism studies, and disease research in pharmaceutical development.

AI & Machine Learning Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Christopher TrummerinCEO & Co-Founder

Ola Spjuth inChief AI Officer (CAIO) & Co-FounderOla Spjuth leads a research group at Uppsala University focused on intelligent systems in drug discovery and toxicology, and is co-founder of Definigen, which manufactures iPSC-derived human hepatocytes for preclinical drug testing and disease modeling.

Jordi Carreras-Puigvert inChief Scientific Officer & Co-FounderJordi Carreras-Puigvert is Chief Scientific Officer and Co-Founder of Definigen, which develops iPSC-derived human hepatocytes and intestinal organoids for drug safety testing and disease modeling. He holds an Associate Professor position at Uppsala University, where he co-leads the Pharmaceutical Bioinformatics group.

Morgan Ekmefjord inCo-Founder & CTOMorgan Ekmefjord is co-founder and CTO of Definigen, which manufactures iPSC-derived human hepatocytes for drug discovery and disease modeling.

Investors · 3

Almi Invest✓ verifiedGothenburg · $100K – $1M

Nordic Science Investments✓ verifiedHelsinki · $55K – $3.9M

24 HaymarketLondon

Founder mafia

4 people who came through Definigen went on to found or lead other companies.

Jonathan MilnerInvestorFounded Bit Bio Ola SpjuthChief AI Officer (CAIO) & Co-FounderFounded Pixl Jordi Carreras-PuigvertChief Scientific Officer & Co-FounderFounded Pixl Morgan EkmefjordCo-Founder & CTOFounded Pixl

Frequently asked questions

What does Definigen do?: Definigen manufactures iPSC-derived human hepatocytes for drug discovery and disease modeling. The product line supports preclinical toxicity testing, metabolism studies, and disease research in pharmaceutical development.
Who founded Definigen?: Definigen was founded by Christopher Trummer, Ola Spjuth, Jordi Carreras-Puigvert, Morgan Ekmefjord.
Who are Definigen's investors?: Definigen's investors include Almi Invest, Nordic Science Investments, 24 Haymarket.
Where is Definigen headquartered?: Definigen is headquartered in Uppsala, SE.